HMD

COM:HERA-MED

Hera Med

  • Stock

Last Close

0.02

22/11 04:57

Market Cap

15.20M

Beta: -

Volume Today

1.98M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
40.91K
-
81.70K
-
63.68K
22.05%
78.88K
23.87%
129.94K
64.73%
307.17K
136.39%
average payables
17.98K
-
463.43K
-
477.44K
3.02%
595.75K
24.78%
626.84K
5.22%
757.10K
20.78%
average receivables
58.23K
-
156.15K
-
184.44K
18.12%
237.97K
29.02%
248.56K
4.45%
378.15K
52.14%
book value per share
0.01
-
0.00
78.36%
0.05
1,663.68%
0.03
45.59%
0.01
-
0.00
81.10%
capex per share
-0.00
-
-0.01
165.68%
-0.00
82.73%
-0.00
15.17%
-0.00
-
-0.00
99.76%
capex to depreciation
-61.40
-
-120.14
95.67%
-0.60
99.50%
-1.93
-
-0.00
99.84%
capex to operating cash flow
0.21
-
1.54
616.66%
0.10
93.45%
0.08
24.57%
0.02
72.42%
0.03
26.11%
0.11
317.45%
0.00
99.67%
capex to revenue
-2.31
-
-1.43
38.19%
-1.48
3.76%
-0.99
33.34%
-3.16
220.08%
-0.00
99.89%
cash per share
0.02
-
0.00
96.85%
0.05
7,205.34%
0.02
49.85%
0.01
-
0.00
67.97%
days of inventory on hand
3.27K
-
286.70
91.23%
190.03
33.72%
800.59
321.29%
764.52
4.50%
799.14
4.53%
145.52
81.79%
days payables outstanding
1.05K
-
664.27
36.69%
1.28K
92.84%
1.49K
16.54%
5.76K
285.94%
5.99K
3.91%
2.61K
56.33%
482.55
81.54%
days sales outstanding
838.09
-
339.20
59.53%
2.16K
536.57%
1.02K
52.76%
425.08
58.33%
302.94
28.73%
debt to assets
0.12
-
0.24
92.31%
0.03
85.84%
0.07
97.54%
0.06
10.31%
0.74
1,141.44%
0.04
94.25%
0.09
106.01%
debt to equity
0.25
-
1.48
500.11%
0.04
97.08%
0.10
134.20%
0.10
5.00%
-32.25
33,725.74%
0.06
100.19%
0.38
512.15%
dividend yield
earnings yield
-0.17
-
-0.06
63.97%
-0.27
339.01%
-0.23
12.73%
-0.36
-
-1.07
193.76%
enterprise value
15.21M
-
17.11M
12.48%
10.16M
40.63%
12.36M
21.65%
-1.71M
113.86%
-140.91K
91.77%
15.78M
11,298.79%
5.56M
64.78%
enterprise value over ebitda
-5.62
-
-20.62
266.91%
-3.53
82.87%
-4.12
16.71%
0.55
113.44%
0.04
93.07%
-5.67
14,849.86%
-0.92
83.69%
ev to operating cash flow
-7.90
-
-23.98
203.42%
-5.75
76.01%
-4.53
21.21%
0.61
113.55%
0.04
92.90%
-2.52
5,881.34%
-0.97
61.45%
ev to sales
131.63
-
85.00
35.43%
-43.33
150.98%
-1.63
96.25%
72.09
4,532.86%
9.16
87.30%
free cash flow per share
-0.03
-
-0.02
22.55%
-0.02
14.35%
-0.03
49.25%
-0.03
-
-0.02
34.91%
free cash flow yield
-0.14
-
-0.11
22.55%
-0.14
28.64%
-0.21
49.25%
-0.38
-
-0.90
135.92%
graham net net
0.01
-
-0.01
264.49%
0.03
358.67%
0.01
68.72%
0.01
-
-0.00
132.13%
graham number
0.09
-
0.03
72.08%
0.22
729.60%
0.15
31.09%
0.10
-
0.04
60.86%
income quality
0.67
-
0.69
2.89%
0.47
32.45%
0.95
-
0.84
10.86%
intangibles to total assets
0.16
-
0.89
439.27%
0.22
75.68%
0.32
48.56%
0.30
5.81%
0.15
51.66%
0.25
70.99%
0
100%
interest coverage
-19.39
-
-4.43
77.14%
-3.22
27.29%
-434.84
13,385.63%
-324.32
25.42%
-2.35
99.27%
-1.81
23.15%
-49.45
2,634.44%
interest debt per share
0.00
-
0.01
31.57%
0.01
99.27%
0.00
77.22%
0.01
-
0.00
83.67%
inventory turnover
0.11
-
1.27
1,040.69%
1.92
50.87%
0.46
76.26%
0.48
4.72%
0.46
4.33%
2.51
449.15%
invested capital
0.25
-
1.48
500.11%
0.04
97.08%
0.10
134.20%
0.10
5.00%
-32.25
33,725.74%
0.06
100.19%
0.38
512.15%
market cap
16.78M
-
16.78M
0%
14.00M
16.54%
14.16M
1.12%
18.22M
-
6.36M
65.11%
net current asset value
785.80K
-
-1.20M
252.45%
3.13M
361.39%
1.14M
63.52%
1.01M
11.50%
-805.33K
179.66%
1.75M
317.05%
-342.73K
119.61%
net debt to ebitda
0.58
-
-0.40
168.26%
1.34
437.88%
0.60
55.00%
0.55
7.98%
0.04
93.07%
0.88
2,179.20%
0.13
84.82%
net income per share
-0.03
-
-0.01
63.97%
-0.04
290.23%
-0.04
12.73%
-0.03
-
-0.03
18.95%
operating cash flow per share
-0.02
-
-0.01
62.93%
-0.02
163.60%
-0.03
52.68%
-0.03
-
-0.02
27.75%
payables turnover
0.35
-
0.55
57.95%
0.28
48.14%
0.24
14.19%
0.06
74.09%
0.06
3.76%
0.14
129.00%
0.76
441.77%
receivables turnover
0.44
-
1.08
147.08%
0.17
84.29%
0.36
111.68%
0.86
139.97%
1.20
40.32%
research and ddevelopement to revenue
8.79
-
6.35
27.80%
29.88
370.79%
17.47
41.54%
3.46
80.18%
3.49
0.75%
return on tangible assets
-1.42
-
-5.66
297.70%
-0.87
84.64%
-1.36
56.17%
-1.55
14.26%
-1.88
21.44%
-2.12
12.65%
-2.30
8.27%
revenue per share
0.00
-
0.00
86.31%
0.00
-
0.00
119.26%
roe
-2.36
-
-3.92
66.50%
-0.87
77.87%
-1.39
60.39%
-1.73
24.34%
69.66
4,125.00%
-2.31
103.32%
-9.92
328.82%
roic
-1.80
-
-1.29
28.15%
-0.79
39.19%
-1.23
56.29%
-1.57
27.92%
-1.54
2.05%
-1.40
8.84%
-7.07
404.21%
sales general and administrative to revenue
23.54
-
8.50
63.89%
29.33
245.13%
20.02
31.74%
7.80
61.05%
shareholders equity per share
0.01
-
0.00
78.36%
0.05
1,663.68%
0.03
45.59%
0.01
-
0.00
81.10%
stock based compensation to revenue
tangible asset value
816.18K
-
-1.18M
244.11%
3.15M
367.54%
1.23M
60.86%
1.03M
16.14%
-776.34K
175.16%
1.82M
334.87%
683.96K
62.49%
tangible book value per share
0.01
-
-0.01
244.11%
0.04
384.95%
0.01
61.29%
0.01
-
0.00
70.34%
working capital
1.43M
-
-313.24K
121.94%
3.82M
1,318.22%
1.82M
52.33%
1.69M
7.03%
-256.11K
115.14%
2.25M
979.64%
419.47K
81.38%

All numbers in (except ratios and percentages)